Status:

COMPLETED

EFFECT of CHEWING GUM on CONTROLLING NAUSEA/VOMITING and THIRST in PATIENTS with ACUTE PANCREATITIS

Lead Sponsor:

TC Erciyes University

Conditions:

Acute Pancreatitis

Thirst

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Nausea and vomiting are one of the most common symptoms in acute pancreatitis. In addition to pharmacological methods for nausea and vomiting, non-pharmacological methods can also be used. Among these...

Eligibility Criteria

Inclusion

  • Those diagnosed with acute pancreatitis,
  • Without total dental prosthesis,
  • Without salivary gland infection,
  • Those who have not had salivary gland surgery,
  • No difficulty in chewing,
  • Not receiving oxygen therapy,
  • Able to answer all questions and be communicativ

Exclusion

  • Those with diabetes,
  • Does not like chewing gum,
  • Receiving radiotherapy or chemotherapy,

Key Trial Info

Start Date :

March 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 29 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06077188

Start Date

March 15 2024

End Date

June 29 2024

Last Update

March 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Erciyes University Hospital

Kayseri, Turkey (Türkiye), 38039